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1. Introduction
During the last decade magnesium and magnesium alloys (MA) were the centre of a large
number of studies especially in Europe [1-3] and Asia [4-6]. The main focus of these studies
was to evaluate the use of magnesium and MA as basic material for clinical applications.
For the treatment of bone fractures, orthopaedic implants made of surgical steel or titanium
are used when weight bearing bones are affected. The major disadvantage of these materials
is that they need to be removed in a second surgery due to implant loosening or intolerance
after longer implantation times resulting in higher costs and stress for the patient. Therefore
resorbable implant materials are needed which complementarily provide sufficient stability
for weight bearing applications.
Magnesium is a light metal which is known to corrode in aqueous solution. Its density is
1.74 g/cm3 at room temperature and therewith 1.6 fold resp. 4.5 fold lower than aluminium
or steel [7]. With prospect of orthopaedic use, its advantages are its appropriate compressive
and tensile strengths as well as its Young’s Modulus (41-45 GPa), which is considerably clos‐
er to cortical bone compared to other metallic implant materials [7-9]. The corrosion rate
ranges between aluminium and unalloyed steel [10].
Magnesium as a mineral occurs naturally in the body and is eliminated through the kidneys
[11,12]. Due to their high excretion ability hypermagnesaemia is rare [13]. Severe symptoms
like arrhythmia, feeling of faintness up to paralyses and/or cardiac or respiratory arrest are
only seen in the course of therapeutical intravenous application [11,14].
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Therefore, magnesium and MA are intensively investigated to develop a basic material for
the production of degradable osteosynthesis implants e.g. plates, screws or intramedullary
nails.
Alloying with other elements such as lithium, aluminium, zinc or rare earth metals aims to
adjust the corrosion resistance and mechanical properties of magnesium [9,15-18]. In engi‐
neering applications Aluminium (Al) as another light metal is often used as alloying com‐
ponent in MA for its beneficial effect of strength, hardness and castability improvement [19].
For an optimum balance between strength and ductility the authors claim a content of 6 wt
%. Contents between 1-9 wt% are classified as corrosion protective, whereof the higher the
content the better the protection [8]. Many groups investigated MA containing Al [20-27],
despite its questionable biocompatibility [28].High concentrations are considered to be neu‐
rotoxic and implicated in pathologies such as dementia, senile dementia and Alzheimer’s
Disease [29]. However according to reference [30] the uptake of even high amounts of Al re‐
sults in physiological neutral behaviour and exceptional low quantities are absorbed. For‐
merly, different groups reported on high corrosion rates of Mg-Al-alloys [20-22], but
recently a decrease in corrosion rate could be shown in comparison to pure Mg or other MA,
especially when further elements e.g. zinc [26,27] or Rare Earth Metals [23,31] are added.
Besides aluminium, Lithium (Li) could be added to increase the ductility and the corrosion
resistance with a simultaneous decrease in strength [8,19,32]. However, the engineering ap‐
plication is limited [19]. In medicine, Li is therapeutically used for the treatment of manic-
depressive disorders. However, a correlation with teratogenicity, nephrotoxicity and mania
is discussed [33].
Zinc is often used in combination with aluminium to improve strength at room temperature
[19]. In combination with zirconium or rare earths it is used to produce MA hardenable by
precipitations and with superior strength. Regarding the corrosion behaviour, zinc lowers
the corrosive effect of iron and nickel impurities [19]. In the body zinc belongs to the essen‐
tial trace elements and is excreted mainly via the faeces. It plays an important role in numer‐
ous processes e.g. protein synthesis, nucleic acids synthesis, carbohydrate and lipid
metabolism [34]. Zinc deficiency is associated with an increase in bone mass and osteoblast
DNA synthesis [35,36].
The main reason for the addition of Zirconium to MA is the purpose of grain refinement.
Although it is a powerful grain refiner it cannot be used in Al-containing MAs because it is
removed from solid solution due to the formation of stable compounds [19]. Such com‐
pounds are also formed with elements like manganese, iron, silicon, carbon, nitrogen, oxy‐
gen or hydrogen when they are present within the melt [19]. Hence, the amount of soluble
zirconium is the important factor rather than the total amount. Zirconia implants have excel‐
lent resistance to corrosion and wear, good biocompatibility and high bending strength and
fracture toughness [37].
The usual addition of Rare Earths (RE) in engineering applications is performed as mis‐
chmetal or didymium, whereof the mischmetal contains 50 wt% cerium and the rest princi‐
pally neodymium and lanthanum [19]. REs aim to increase the strength of MA and to
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decrease weld cracking and porosity during the casting procedure [19]. Regarding the de‐
velopment of a resorbable implant material it is important, that the addition of RE can ach‐
ieve an increase of the corrosion resistance [23,38-40]. However, this also depends on the
other alloying elements. In reference [41] was reported on a decrease of the corrosion resist‐
ance in vitro after combining Al and Neodymium with Mg as main alloying component.
There are controversial reports about the effect and toxicity of REs. Especially high concen‐
trations are considered to have toxic effects [42-45].On the other hand a bone-protective ef‐
fect and an increase in bone density could be shown after a six months feeding trial [46].
Low amounts of REs in MA were appraised as well tolerable in reference [28]. In reference
[45] the short-term effect of REs in vitro was evaluated. The authors assessed the responses
of different cell lines after the addition of the single RE elements and found differences be‐
tween light (Lanthanum (La), Cerium (Ce), Praseodymium (Pr)) and medium to heavy (Ne‐
odymium (Nd), Europium (Eu), Gadolinium (Ga) and Dysprosium (Dy)) RE elements: light
RE elements showed toxic effects at lower concentrations [45]. They concluded that La and
Ce should be used only when absolutely necessary. Most of the contemporarily published in
vivo examinations used MA with low amounts of REs, which were added as mischmetal
[2,9,40,47-50]. This mischmetal can actually differ depending on the time and/or date of pur‐
chase. For example, [45] determined the RE mixture of WE43 to be mainly Nd, Gd and Dy
whereas in the most commercially available RE composition metals Ce, Nd and La form the
major fraction [44,51]. In in vivo examinations, LAE442, a MA with 4 wt% lithium, 4 wt%
aluminium and 2 wt% REs showed generally good biocompatibility with slow and homoge‐
nous degradation properties [1,2,23,47]. Nevertheless, in reference [3] was pointed out, that
from a medical point of view the addition of such a content-varying mixture has to be seen
very critically since reproducibility is one of the main requirements for medical devices.
Hence, they examined the in vivo degradation behaviour of this repeatedly used MA
LAE442 in comparison to LACe442 which replaced the RE mixture by the single RE element
Cerium. The outcome of this in vivo study supported the simultaneously performed exami‐
nations described in reference [45] as this replacement led to a severe increase of the degra‐
dation rate with subsequent tissue reactions. Therefore the authors concluded that Ce could
not supersede the RE composition. So far unknown regulative effects between the different
RE elements seem to exist.
But despite the good results of LAE442, the effort to replace the mixture by a single element
is still reasonable to achieve a most accurate implant device.
Since in reference [45] Nd was classified as suitable, referring to LAE442, LANd442 was de‐
veloped as well as Nd2 and their in vitro corrosion behaviour was assessed [41]. They
showed that the corrosion rate for Nd2 was lower than for LANd442. However, the applica‐
tion of a MgF2-coating lowered the corrosion rate of LANd442. After these positive results,
LANd442 was introduced into in vivo experiments. Parts of this study will be included in
the next subchapter.
Some groups reported on the fact that in vitro and in vivo degradation properties could dif‐
fer considerably [6,24]. Thus, besides profound in vitro tests like bending tests, corrosion
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tests or microstructure characterisation to identify and adjust the material properties, the in
vivo degradation behaviour and biocompatibility has to be investigated thoroughly.
Besides other animal models e.g. rats and sheep, the rabbit is a well established laboratory
animal in orthopaedic research [52-54].
2. In vivo experiments
To investigate the clinical applicability of different RE containing MA the rabbit (female
New Zealand White rabbits, body weight > 3 kg) was chosen as animal model. Partially, the
results of the following data have already been published or submitted [55-57]. Extruded,
cylindrical pins (length 25 mm, diameter 2.5 mm) were produced and washed in acetone for
eliminating fabrication residues. Sterilization was carried out by gamma irradiation. Ten im‐
plants of three different RE containing MA were produced: LAE442, LANd442 and ZEK100.
These cylinders were randomly implanted into the middle third of the tibial medullary cavi‐
ty (Fig 1), one in each hind leg. The follow up period was six months. Clinical examinations
were performed regularly to assess the clinical tolerance of the implants.
Figure 1. X-ray depiction of an implanted MA-pin with marked µ-CT scan area.
µ-Computed tomography is a non-destructive analysing method to assess changes within
the structure of either engineering components or medical implants [2,40,58,59]. It can also
be used to evaluate the reactions of the surrounding tissue to implanted orthopaedic devices
after in vivo examinations [57,60,61]. However, the laboratory animals have to be sacrificed
for these investigations. To evaluate the proceeding degradation and to perform a proper in‐
itial-to-end-value comparison in vivo µ-computed tomography scans have been introduced
recently [50,55,57,60,62]. Further they allow for a reduction of laboratory animals as the re‐
sults after different implantation periods could be gained from the same animal.
For the presented study an XtremeCT (Fa. Scanco Medical, Zurich, Switzerland) was used.
The animals were scanned in general anaesthesia and in supine position (Fig.2). The scan
was performed from the knee joint space up to approx. 5 mm beneath the implant (Fig.1)
with a resolution of 41 µm, 1000 projections at 0-180° and an integration time of 100 ms. The
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electron energy used was 60 kVp and the intensity was 900 µA. In the first eight weeks the
rabbits were scanned biweekly, afterwards every four weeks.
Figure 2. µ-computed tomography of the rabbit tibia under general anaesthesia.
The µ-computed tomography evaluation included three parts: First, the implant itself was
assessed (changes in structure and volume of the pins as well as their corrosion morpholo‐
gy). For each implant material a specific threshold was determined which represented the
pin most accurately (LAE42 and LANd442: 138, ZEK100: 127).The implants were subse‐
quently manually outlined and measured by means of the software µCT evaluation pro‐
gram V6.1 (XtremeCT, Fa. Scanco Medical, Zurich, Switzerland). To further quantify the
corrosion rate and the corrosion morphology, the direct 3D thickness of the volumes of in‐
terest (VOIs) was calculated. Therefore, the structure was filled with overlapping spheres of
maximal diameter. The diameter of the spheres at tach location denotes the local thickness.
The average thickness was determined by averaging over the whole structure resulting in
histograms of bin sizes with an average 3D thickness and a standard deviation for each im‐
plant. A low average bin size with a low standard deviation indicates a high degree of uni‐
form corrosion. A high standard deviation of the histogram is caused by an irregular shape
of the remaining implant and therefore it is an indicator for the extent of pitting corrosion
[55].
Second the gas which emerged during the degradation process of magnesium implants was
assessed. The corrosion mechanism of pure Mg and MA consists of two electrochemical
parts: the anodic partial reaction forms Mg2+ and 2e-, whereas the cathodic partial reaction
evolves hydrogen and 2OH- from the reaction of water with the 2e- [10,63,64]. In vitro corro‐
sion tests of MA which quantify the amount of emerging gas utilize this mechanism [41].
Many in vivo studies reported on the emergence of gas during the course of MA-implant
degradation either as diffuse accumulation or palpable and non-palpable gas bubbles un‐
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derneath the skin [23,55,58,65]. It is a continuous discussion, if these bubbles actually con‐
tain hydrogen. Hence, as a supplementary investigation a gas-tight syringe was used to
gather the emerged gas (approx. 0.5 ml) out of a large subcutaneous gas bubble. It was sent
to the Institute of Organic Chemistry, Technical University Braunschweig, and analyzed.
However, it was not possible to verify pure hydrogen. The most likely explanation is that
the highly volatile gas undergoes rapid exchange with the surrounding tissue. From the au‐
thors’ point of view there is no need to doubt that the degrading magnesium implants are
the source of the gas independent on the actual composition in the bubbles as faster degrad‐
ing alloys subjectively generate higher amounts of gas. This leads to the matter of quantify‐
ing the gas volume. So far, no method has been described to report on the quantity of gas
emerged particularly over the course of time. So within this second part of the µCT evalua‐
tion a method for quantifying the gas volume using the XtremeCT was established. Within
the 2D-slices of the µCT-scans of the LAE442 group, the occurring gas was manually out‐
lined and measured by means of the software µCT evaluation program V6.1. The threshold
of the grey values was determined to be between -1000 and 25.
With proceeding degradation the corrosion products influence the surrounding tissue. The
smaller the impact of the implant the better is its biocompatibility. On the one hand it could
be generally said, that an implant is biocompatible when its functionality is achieved with‐
out inducing a foreign body reaction [66]. On the other hand, according to the Conference
1984 of the European Society for Biomaterials, biocompatibility is the ability of a material to
fulfil its purpose for a specific application with an appropriate host response [67]. This defi‐
nition includes the fact that every inserted implant actually could/will influence the sur‐
rounding tissue in one or another way and emphasize on the adequacy. The reactions which
are described are either foreign body reactions ([3,57,60,65] or structural changes of the bone
[2,57,61]. To assess cellular reactions histological examinations have to be carried out. How‐
ever, µCT is a well-established tool to evaluate structural changes of the bone. Thus, as a
third part of the µCT evaluation the impact of the degrading implant on the adjacent bone
was evaluated by a quantitative determination of the bone density (in mg HA/cm3), the
bone volume (in mm³/slice) and the bone porosity (in percent). The bone volume which was
included into the evaluation was defined by choosing those slices in which also the implant
was seen. Hence, the bone directly adjacent to the implant was manually outlined. The
threshold value for the subsequent evaluations was determined to be 160 and the same soft‐
ware was used as for the implant and gas evaluation. Due to internal processing, the latest
investigation time for ZEK100 was week 20.
2.1. Pin degradation
The density is given in the unit mg HA/mm³ (milligram hydroxyapatite per cubic millime‐
tre) which is the unit the XtremeCT gives for the density of mineralized tissue such as bone.
Therefore, the indicated density values do not correspond to common used alloy density
values but allow for a comparison of the three alloys investigated among each other. Their
density differed from the beginning of the implantation period. LAE442 density was higher
than LANd442. ZEK100 showed the lowest density (Fig. 3). Besides the varying alloying
Magnesium Alloys6
components different grain sizes of the alloy could influence the density [68] and therefore
cause the detected differences. During the course of degradation LAE442 showed only a
slight decrease in density with a very low standard deviation. Also the density of LANd442
implants diminished slightly, however the standard deviation was obviously higher imply‐
ing a more inhomogeneous procedure. ZEK100 implants showed the highest loss in density.
The initial volume of all alloys ranged in similar values. According to the density, LAE442
implants showed only a minor decrease over the implantation period and demonstrated
again a low standard deviation. The changes of volume in LANd442 implants also matched
the results of the density. A slight decrease could be found with a higher standard deviation
in comparison to LAE442. ZEK100 pins demonstrated an obvious loss of volume particular‐
ly from the 12th week on with an exceptional high standard deviation in the later scan weeks
(Fig. 3).
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Figure 3. Volume and density changes of LAE442, LANd442 and ZEK100 implants over the implantation duration of
24 weeks.
These results indicate a slow and uniform degradation of LAE442 implants. LANd442 pins
also degraded slowly but less uniformly. ZEK100 showed an equally slow degradation
within the first weeks of implantation. This process accelerated distinctly resulting in inho‐
mogeneous pin geometries.
Rare Earth Metals as Alloying Components in Magnesium Implants for Orthopaedic Applications
http://dx.doi.org/10.5772/48335
7
The examination of the true 3D-thickness confirmed these findings (Fig. 4). Corresponding
to the volume and density changes, the average diameter of the spheres and thus the true
3D-thickness of LAE442 implants underlay only minor changes in the course of degradation.
The low and uniform variance of diameter is a sign for a very homogeneous degradation.
LANd442 implants showed a slight decrease of the true 3D-thickness. The variance of diam‐
eter increased in the course of implantation moderately. Taken together both results it could
be said that LANd442 pins degraded slowly but faster and more inhomogeneous than
LAE442. ZEK100 displayed the most obvious changes. From the 8th week on the average di‐
ameter of the spheres decreased continuously while the variance of diameters showed a pro‐
found increase. Consequently, ZEK100 implants degraded fast and irregularly.
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Figure 4. True 3D-thickness and variance of diameter as indicator for homogeneous or heterogeneous degradation of
the implanted LAE442, LANd442 and ZEK100 pins, respectively.
The colour mapping of the degraded implants after six months implantation duration in
comparison to an undegraded implant visualized the differences of the pin geometry (Fig.
5).
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2.2. Gas volume
In outlining and evaluating the occurring gas within the marrow cavity it was possible to
quantify the gas volume during the course of degradation.
It is noteworthy that a distinct proceeding decrease in volume was found until week 12 fol‐
lowed by a continuous increase. This could be explained by the fact that a certain amount of
gas was brought into the marrow cavity due to the surgical procedure. This gas volume is
reabsorbed by the organism in the subsequent time. Corresponding to the beginning degra‐
dation of the implant, which is represented by the volume and density changes (Fig. 6 and
7), the amount of gas which is emerged exceeded the absorption capacity of the organism
resulting in the increase of gas volume.
 
Figure 5. depiction and colour mapping of a MA-cylinder before implantation and of MA-cylinders (alloys: LAE442,
LANd442 and ZEK100) after six months implantation period in the rabbit tibia.
Fig. 8 shows a 3D-evaluation of the bone (transparent) with implanted MA-cylinder (blue)
and surrounding gas (brown).
For further examinations, this method can be used to compare the gas volume with possible
occurring changes of the surrounding tissue.
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Figure 6. Quantity of gas volume and pin density of LAE442 cylinders over six months implantation duration meas‐
ured by µ-computed tomography (XtremeCT, Scanco medical).
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Figure 8. depiction of an implanted MA-cylinder (blue) within the tibia diaphysis (yellow-transparent) surrounded by
gas (brown-red).
2.3. Changes in bone structure
The bone adjacent to all three types of implanted MA pins lost density during the course of
degradation (Fig. 9). For LAE442 implants the decrease in density was more pronounced in
the first weeks of implantation and slowed down in the following period. From week 12 on
only a negligible further decrease could be seen. LANd442 also showed a moderate decrease
in bone density up to week 12 followed by an increase in the next four weeks and subse‐
quent steady state until week 24. Due to the lower number of investigations the density
course of ZEK100 implants appeared to be different. They induced a proceeding reduction
of the bone density over the total investigation period. However, a higher number of investi‐
gations could reveal a similar pattern as for LAE442 and LANd442.
The bone volume (specified per slice) increased over the investigated time period.
No distinct differences could be found for the different MA cylinders (Fig. 10).
In contrast to the aforementioned results the changes in porosity of the bone showed no reg‐
ular pattern (Fig. 11). The bone porosity adjacent to LAE442 implants first increased up to
week 4, followed by a decrease up to week 12. Afterwards the bone porosity again increased
up to the end of the investigation period but slower than in the beginning. LANd442 im‐
plants showed only minor changes within the first 12 weeks. After that the porosity in‐
creased first moderately up to week 16 and from then on intensely till the end of
investigation. However this increase in the LANd442 mean value is particularly caused by
one implant which degraded severely faster than all other implants of the same group with‐
out any obvious explanation. The high standard deviation for the scans in week 16 and 24
illustrated this fact. If this cylinder would be excluded from the evaluation the mean porosi‐
ty of the LANd442 pins would steadily decrease from week 8 on up to week 24. After the
implantation of ZEK100 cylinders a distinct increase in bone porosity could be seen in the
first eight weeks followed by a moderate decrease up to week 20.
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 Figure 9. Bone density adjacent to implanted LAE442-, LANd442- and ZEK100-cylinders in the course of implantation
over up to 24 weeks.
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 Figure 10. Bone volume/slice adjacent to implanted LAE442-, LANd442- and ZEK100-cylinders in the course of im‐
plantation over up to 24 weeks.
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 Figure 11. Bone porosity adjacent to implanted LAE442-, LANd442- and ZEK100-cylinders in the course of implanta‐
tion over up to 24 weeks.
Taken into account all gathered results the µ-computed tomography evaluation of the bone
structure illustrated the bone remodelling processes well. The increase in bone volume indi‐
cated endosteal and periosteal new bone growth. The simultaneous decrease in bone density
can be explained by the fact that this newly formed bone is not as dense as the mature bone.
The varying porosity depends on two different factors. On the one hand the state of the
bone remodelling process influences this value. The newly formed bone is not as much
structured as the mature bone and therefore shows a higher porosity. Since the bone of
LAE442 implants showed a higher increase in bone volume accompanied by the most dis‐
tinct decrease in density particularly in the first weeks of implantation the ascending porosi‐
ty at this time could be explained. On the other hand the two-dimensional evaluation which
was not included here showed that the faster degrading ZEK100 implants induced more
bone cavities than the slower degrading alloys [65]. This is probably the cause for the initial
increase in porosity. To which extend the decreasing density influences the computation of
the porosity remains to be shown as the further degrading ZEK100 cylinders should contin‐
uously increase the porosity instead of the determined however slight decrease.
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3. Conclusions
After considering both the accessible literature and the presented results, REs seem useful
and maybe even necessary alloying components in MA basis material for the production of
orthopaedic implants.
It could be shown that the addition of REs lead to mostly biocompatible, degradable im‐
plants with however different degradation characteristics.
LAE442 proved to be the slowest degrading alloy with the lowest influence on the sur‐
rounding tissue. The replacement of the RE composition metal by the single element Nd did
not result in improvement of the biocompatibility nor of the degradation behaviour. Contra‐
ry, these LANd442 implants showed a less regular corrosion process than LAE442 cylinders.
Therefore LAE442 implants should be favoured over LANd442. Therewith, two alloys
which aimed to replace the RE composition by a single element (LANd442, LACe442 [3])
failed in exceeding the good degradation behaviour and biocompatibility of LAE442.
ZEK100 as a completely different approach to develop an alloy for orthopaedic implant pro‐
duction clearly showed inferior results by degrading inhomogeneously and causing signifi‐
cant structural changes in the adjacent bone and tissue [55].
In principal, a slow degrading MA should be developed as a faster degradation is correlated
with a reduced clinical tolerance and an increased impact on the adjacent bone: the implant
in the right leg of one LANd442 rabbit degraded significantly faster than the other implants.
The animal showed a moderate to severe lameness of the affected leg and an obvious in‐
crease in bone porosity. Also in reference[3] was reported on the poor biocompatibility of
LACer442 which degraded very fast.
Altogether, the perfect composition of a degradable MA implant material has not been de‐
veloped yet. Regarding the biocompatibility, Li-Al-RE-containing MA turned out to be very
promising. However, to satisfy the high standards for the production of medical devices ef‐
forts to replace the RE composition metal by one or even a couple of the single RE elements
should not be abandoned with further focus on a slow and homogenous degradation behav‐
iour.
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